Author:
Cottreau Jessica M.,Christensen Alyssa B.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialized Nursing,Orthopedics and Sports Medicine
Reference9 articles.
1. The 10 × ′20 initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020;Clinical Infectious Diseases,2010
2. Delafloxacin: Place in therapy and review of microbiologic, clinical and pharmacologic properties;Jorgensen;Infectious Diseases Therapy,2018
3. Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): A randomised, controlled, double-blind, phase 3, non-inferiority trial;Kollef;The Lancet Infectious Diseases,2019
4. Safety and efficacy of prolonged use of dalbavancin in bone and joint infections;Morata;Antimicrobial Agents and Chemotherapy,2019
5. RESTORE-IMI 1: A multicenter, randomized, double-blind trial comparing efficacy and safety of imipenem/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections;Motsch;Clinical Infectious Diseases,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献